A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China

NCT03872830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: Felbinac Trometamol Injection
DRUG: Placebos

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd